Literature DB >> 25920625

The many facets of RNA-binding protein HuR.

Johnson Rajasingh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25920625      PMCID： PMC4747040          DOI： 10.1016/j.tcm.2015.03.013

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


× No keyword cloud information.
  18 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

Review 2.  RNA-binding proteins.

Authors:  Min-Ho Lee; Tim Schedl
Journal:  WormBook       Date:  2006-04-18

3.  HuR recruits let-7/RISC to repress c-Myc expression.

Authors:  Hyeon Ho Kim; Yuki Kuwano; Subramanya Srikantan; Eun Kyung Lee; Jennifer L Martindale; Myriam Gorospe
Journal:  Genes Dev       Date:  2009-07-02       Impact factor: 11.361

4.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.

Authors:  Alan D Lopez; Colin D Mathers; Majid Ezzati; Dean T Jamison; Christopher J L Murray
Journal:  Lancet       Date:  2006-05-27       Impact factor: 79.321

5.  Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice.

Authors:  Prasanna Krishnamurthy; Erin Lambers; Suresh Verma; Tina Thorne; Gangjian Qin; Douglas W Losordo; Raj Kishore
Journal:  FASEB J       Date:  2010-03-10       Impact factor: 5.191

6.  N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells.

Authors:  Yang Wang; Yue Li; Julia I Toth; Matthew D Petroski; Zhaolei Zhang; Jing Crystal Zhao
Journal:  Nat Cell Biol       Date:  2014-01-07       Impact factor: 28.824

Review 7.  RNA-stabilizing proteins as molecular targets in cardiovascular pathologies.

Authors:  Sahana Suresh Babu; Darukeshwara Joladarashi; Prince Jeyabal; Rajarajan A Thandavarayan; Prasanna Krishnamurthy
Journal:  Trends Cardiovasc Med       Date:  2015-02-20       Impact factor: 6.677

8.  The RNA-binding protein repertoire of embryonic stem cells.

Authors:  S Chul Kwon; Hyerim Yi; Katrin Eichelbaum; Sophia Föhr; Bernd Fischer; Kwon Tae You; Alfredo Castello; Jeroen Krijgsveld; Matthias W Hentze; V Narry Kim
Journal:  Nat Struct Mol Biol       Date:  2013-08-04       Impact factor: 15.369

Review 9.  HuR: a promising therapeutic target for angiogenesis.

Authors:  Rui Dong; Guo-Dong Yang; Nian-An Luo; Ya-Qi Qu
Journal:  Gland Surg       Date:  2014-08

10.  Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability.

Authors:  Neelanjan Mukherjee; David L Corcoran; Jeffrey D Nusbaum; David W Reid; Stoyan Georgiev; Markus Hafner; Manuel Ascano; Thomas Tuschl; Uwe Ohler; Jack D Keene
Journal:  Mol Cell       Date:  2011-06-30       Impact factor: 17.970
View more
  3 in total

1.  Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.

Authors:  Samuel Slone; Sarah R Anthony; Xiaoqing Wu; Joshua B Benoit; Jeffrey Aube; Liang Xu; Michael Tranter
Journal:  Cell Signal       Date:  2016-08-10       Impact factor: 4.315

2.  Human antigen R as a therapeutic target in pathological cardiac hypertrophy.

Authors:  Lisa C Green; Sarah R Anthony; Samuel Slone; Lindsey Lanzillotta; Michelle L Nieman; Xiaoqing Wu; Nathan Robbins; Shannon M Jones; Sudeshna Roy; A Phillip Owens; Jeffrey Aube; Liang Xu; John N Lorenz; Burns C Blaxall; Jack Rubinstein; Joshua B Benoit; Michael Tranter
Journal:  JCI Insight       Date:  2019-02-21

3.  Interplay between RNA-binding protein HuR and Nox4 as a novel therapeutic target in diabetic kidney disease.

Authors:  Qian Shi; Doug-Yoon Lee; Denis Féliers; Hanna E Abboud; Manzoor A Bhat; Yves Gorin
Journal:  Mol Metab       Date:  2020-02-28       Impact factor: 7.422
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.